Multiple cytokines have been identified as potential mediators between prostatic inflammation and prostate cancer risk and aggressiveness including IL-6, IL-2 and transforming growth factor β (TGFβ)7,8. This evidence concerns the gene TGFB1 and Familial prostate cancer.